Semaglutide is a medication used for weight management and the treatment of type 2 diabetes
But for those who menstruate, these changes often come with a hormonal ripple effect, one that can catch people off guard
Retatrutide is the injectable triple agonist that hits GLP-1, GIP, and glucagon receptors at once, and it reached up to 24.2 percent average body weight loss in its Phase 2 obesity trial
If fatigue persists, our HGH program may support energy and recovery during your GLP-1 treatment
There is no preparation required before a glutathione and vitamin C treatment
While women are included in many GLP-1 and obesity trials, enrollment proportions and subgroup reporting remain inconsistent (Rivera et al., 2024)